From: Whole gene expression profile in blood reveals multiple pathways deregulation in R6/2 mouse model
 | Gene set name | SIZE | ES | NES | NOM p-val | FDR q-val | FWER p-val |
---|---|---|---|---|---|---|---|
KEGG | COMPLEMENT AND COAGULATION CASCADES | 61 | 0.69 | 2.56 | 0.000 | 0.000 | 0.000 |
PPAR SIGNALING PATHWAY | 60 | 0.56 | 2.02 | 0.000 | 0.004 | 0.006 | |
GLYCINE SERINE AND THREONINE METABOLISM | 29 | 0.60 | 1.87 | 0.002 | 0.023 | 0.057 | |
PRIMARY BILE ACID BIOSYNTHESIS | 15 | 0.69 | 1.77 | 0.006 | 0.044 | 0.137 | |
RIBOSOME | 82 | 0.45 | 1.73 | 0.000 | 0.052 | 0.199 | |
LYSINE DEGRADATION | 43 | 0.48 | 1.63 | 0.007 | 0.126 | 0.483 | |
HISTIDINE METABOLISM | 28 | 0.53 | 1.62 | 0.020 | 0.110 | 0.488 | |
SYSTEMIC LUPUS ERYTHEMATOSUS | 54 | 0.46 | 1.62 | 0.007 | 0.101 | 0.505 | |
PEROXISOME | 73 | 0.43 | 1.60 | 0.002 | 0.105 | 0.565 | |
PENTOSE PHOSPHATE PATHWAY | 23 | 0.55 | 1.59 | 0.013 | 0.100 | 0.582 | |
BUTANOATE METABOLISM | 30 | 0.51 | 1.59 | 0.007 | 0.095 | 0.598 | |
CYSTEINE AND METHIONINE METABOLISM | 33 | 0.47 | 1.54 | 0.026 | 0.131 | 0.736 | |
BIOSYNTHESIS OF UNSATURATED FATTY ACIDS | 18 | 0.55 | 1.53 | 0.035 | 0.134 | 0.770 | |
TYROSINE METABOLISM | 35 | 0.46 | 1.51 | 0.031 | 0.144 | 0.822 | |
PRION DISEASES | 32 | 0.47 | 1.51 | 0.024 | 0.140 | 0.831 | |
ONE CARBON POOL BY FOLATE | 16 | 0.55 | 1.47 | 0.043 | 0.177 | 0.910 | |
SELENOAMINO ACID METABOLISM | 25 | 0.48 | 1.46 | 0.047 | 0.171 | 0.916 | |
FATTY ACID METABOLISM | 33 | 0.45 | 1.44 | 0.047 | 0.193 | 0.948 | |
AMINOACYL TRNA BIOSYNTHESIS | 41 | 0.42 | 1.40 | 0.048 | 0.241 | 0.977 | |
CARDIAC MUSCLE CONTRACTION | 69 | −0.5 | −1.83 | 0.000 | 0.044 | 0.051 | |
DILATED CARDIOMYOPATHY | 87 | −0.46 | −1.74 | 0.000 | 0.075 | 0.163 | |
REACTOME | FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 31 | 0.7 | 2.20 | 0.000 | 0.002 | 0.001 |
BILE ACID AND BILE SALT METABOLISM | 23 | 0.73 | 2.18 | 0.000 | 0.001 | 0.001 | |
COMPLEMENT CASCADE | 23 | 0.71 | 2.10 | 0.000 | 0.003 | 0.007 | |
LIPOPROTEIN METABOLISM | 26 | 0.67 | 2.05 | 0.000 | 0.007 | 0.019 | |
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 74 | 0.53 | 2.01 | 0.000 | 0.010 | 0.034 | |
CHYLOMICRON MEDIATED LIPID TRANSPORT | 16 | 0.73 | 2.00 | 0.000 | 0.009 | 0.039 | |
INTRINSIC PATHWAY | 17 | 0.73 | 1.99 | 0.000 | 0.008 | 0.040 | |
METABOLISM OF AMINO ACIDS AND DERIVATIVES | 188 | 0.45 | 1.98 | 0.000 | 0.009 | 0.052 | |
LIPID DIGESTION MOBILIZATION AND TRANSPORT | 41 | 0.58 | 1.95 | 0.002 | 0.011 | 0.070 | |
SYNTHESIS OF BILE ACIDS AND BILE SALTS | 18 | 0.69 | 1.91 | 0.004 | 0.016 | 0.109 | |
SULFUR AMINO ACID METABOLISM | 24 | 0.61 | 1.84 | 0.002 | 0.035 | 0.239 | |
PEPTIDE CHAIN ELONGATION | 81 | 0.45 | 1.74 | 0.000 | 0.094 | 0.548 | |
CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | 31 | 0.51 | 1.63 | 0.011 | 0.238 | 0.888 | |
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 36 | 0.49 | 1.62 | 0.007 | 0.248 | 0.917 | |
BIOCARTA | COMP PATHWAY | 16 | 0.75 | 2.02 | 0.000 | 0.021 | 0.017 |
INTRINSIC PATHWAY | 23 | 0.67 | 2.00 | 0.000 | 0.012 | 0.019 | |
 | TOB1 PATHWAY | 19 | 0.61 | 1.70 | 0.011 | 0.224 | 0.412 |